注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Gritstone bio Inc是一家生物技术公司。该公司通过疫苗载体、自扩增mRNA (samRNA)和黑猩猩腺病毒(ChAd)发现、开发、制造和提供下一代癌症和传染病免疫治疗候选药物。其处于临床阶段开发的两个肿瘤学项目是 GRANITE(基于新抗原的个体化免疫疗法)和SLATE(一种现成的基于新抗原的共享免疫疗法)。该公司拥有一个传染病管道,其中包括两个处于临床阶段开发的项目:CORAL,一个可能具有泛冠状病毒潜力的第二代COVID-19疫苗项目,以防止未来的冠状病毒大流行,以及一种 HIV 治疗/治愈疫苗 与 Gilead Sciences, Inc. 合作的候选产品包括GRT-C907 (ChAd)/R908 (samRNA)、GRT-C909 (ChAd)/R910 (samRNA)、GRT-C909 (ChAd)/R910 (samRNA) )、GRT-R914 (samRNA)、GRT-R912 (samRNA)和GRT-R918 (samRNA)。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Elaine V. Jones | 66 | 2019 | Independent Chairman of the Board |
Andrew R. Allen | 54 | 2015 | Co-Founder, President, CEO & Director |
Jean-Charles Soria | 50 | 2020 | Member of Scientific Advisory Board |
Steve Edward Krognes | 54 | 2018 | Independent Director |
Lawrence Corey | 76 | 2022 | Independent Director |
Eugene Zhukovsky | 64 | 2019 | Member of Scientific Advisory Board |
Naiyer A. Rizvi | 59 | 2016 | Independent Director & Member of Scientific Advisory Board |
Graham Lord | - | 2017 | Member of Scientific Advisory Board |
Alessandro Sette | - | 2017 | Member of Scientific Advisory Board |
James L. Gulley | - | 2017 | Member of Scientific Advisory Board |
Clare Fisher | 50 | 2022 | Independent Director |
Timothy A. Chan | - | 2017 | Member of Scientific Advisory Board |
Shefali Agarwal | 50 | 2021 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核